Tiger Brokers

  • Quotes
  • Invest
  • Pricing
  • Download
  • Rewards
  • Help
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
  • About
    • About us
    • Newsroom
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

Evoke Pharma

3.14
-0.0900-2.79%
Post-market: 3.140.00000.00%16:00 EDT
Volume:11.63K
Turnover:37.30K
Market Cap:4.69M
PE:-1.12
High:3.27
Open:3.24
Low:3.13
Close:3.23
Loading ...
OverviewCompanyNewsFilings
Jan 30, 2023

Major Issues Report

8-K - Current report
Nov 30, 2022

Major Issues Report

8-K - Current report
Nov 09, 2022

Major Issues Report

8-K - Current report
Nov 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 20, 2022

Major Issues Report

8-K - Current report
Aug 26, 2022

Major Issues Report

8-K - Current report
Aug 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 10, 2022

Major Issues Report

8-K - Current report
Jun 08, 2022

Major Issues Report

8-K - Current report
May 23, 2022

Major Issues Report

8-K - Current report
May 20, 2022

Major Issues Report

8-K - Current report
May 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 10, 2022

Major Issues Report

8-K - Current report
Apr 28, 2022

Major Issues Report

8-K - Current report
Apr 26, 2022

Major Issues Report

8-K - Current report
Mar 08, 2022

Major Issues Report

8-K - Current report
Mar 08, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 24, 2022

Major Issues Report

8-K - Current report
Feb 17, 2022

Major Issues Report

8-K - Current report
Feb 02, 2022

Major Issues Report

8-K - Current report
More

Analyst Rate

Buy
Buy
100.00%
Hold
0.00%
Sell
0.00%

Corporate Actions

Financial Report Announcement
Mar 13, 2025 Post Market
Financial Report Announcement
Nov 07, 2024 Post Market
Financial Report Announcement
Aug 13, 2024 Pre-Market
Split&Reverse Split
Aug 01, 2024 12 for 1
Financial Report Announcement
May 14, 2024 Post Market

Dividend History

no data

No relevant data is available

Valuation Analysis

-1.25
Current
-2.80
Sector Average
51.50%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-1.25
Maximum
-0.28
+1 STD
0.41
Minimum
-13.56
-1 STD
-6.02
Average
-2.80

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Fintech (Singapore) Pte. Ltd.
Email Address:
uservice@ttm.financial
User Agreement|Privacy Policy

Copyright © Tiger Fintech (Singapore) Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.